Phase 1 Clinical Trials Program

Karmanos’ Phase 1 Clinical Trials Multidisciplinary Team conducts clinical research studies with new, investigational cancer drugs.

Phase 1 trials are the first stage of clinical trials in the careful process of developing new cancer treatments. A typical Phase 1 clinical trial evaluates how a new drug should be given, either orally or injected into the blood, how often, and what dosage is safe. A Phase I trial is often the first time a drug has been given to human, or the first time a new drug has been given to a human in combination with another standard cancer treatment.

Evaluation and Diagnosis

Each patient receives personal attention from the Phase 1 Team. All patients considered for a Phase 1 clinical trial must go through an initial screening consultation to determine if they are eligible for a research study and if a clinical trial is their best treatment option. Once it is determined if they are eligible, patients will go to our dedicated Phase I clinic, Eisenberg Center for Translational Therapeutics, within the Karmanos Cancer Center in Detroit for their appointments.

Patient safety and care are our top priorities. Phase 1 Team physicians, nurse practitioners and physician assistants monitor patients carefully for any changes in their condition and will maintain close contact with referring physicians. Patients may opt-out of a clinical trial at any time.

Innovative, Individualized Care

Here’s what patients can expect from our Phase 1 Clinical Trials Multidisciplinary Team:

A passionate, caring, expert team, giving the best chance of success.
A collaborative approach that considers all available treatment options.
A carefully constructed treatment plan designed to achieve the best possible outcome.
Respectful, compassionate care that is responsive to the emotional needs and lifestyle of a patient.
Proactive, timely communication with patients, caregivers and the referring physician.